MIMOSA PUDICA-LOADED NANOEMUGEL: A PROMISING TOPICAL SYSTEM FOR SKIN CANCER MANAGEMENT
DOI:
https://doi.org/10.22159/ajpcr.2025v18i9.55567Keywords:
Mimosa pudica,, Skin cancer, Cytotoxicity, NanoemugelAbstract
Objectives: The skin, being the body’s largest organ, functions as a vital protective barrier but is highly vulnerable to environmental challenges, including chemical mutagens and carcinogens encountered daily. This study focuses on the development and characterization of Mimosa pudica-loaded PLAROsomes nanoemugel for enhanced therapeutic efficacy against skin cancer.
Methods: A nanoemugel containing M. pudica extract (2.5% w/w) and Carbopol Ultrez 10 NF (2.5% w/w) using a modified formulation approach. The objective was to enhance the solubility, permeation, and therapeutic efficacy of M. pudica for treating skin cancer. The formulation incorporated rose oil and oleic acid, combined with Tween 20 and propylene glycol as a Smix system. Comprehensive evaluation of the nanoemugel was conducted, including in vitro drug release, viscosity assessment, thermal and morphological analyses (scanning electron microscopy and transmission electron microscopy [TEM]), globule size distribution, zeta potential measurement, in vitro cytotoxicity through the MTT assay.
Results: The thermal analysis of the formulation revealed its thermal stability and highlighted potential interactions between the M. pudica extract and the PLARosomal matrix. The nanoemugel demonstrated a globule size of 122.9 nm, with TEM analysis confirming particle agglomeration and circular morphology, measuring 82.3±12 nm. A sustained drug release profile was observed, with cumulative release reaching 68.25% over 48 h. Stability studies confirmed the formulation’s robustness under storage conditions. In vitro cytotoxicity assays on cancer cells showed enhanced efficacy, with a cell viability percentage of 50.21% at a concentration of 100 μg mL-1.
Conclusion: These findings indicate that M. pudica-loaded PLAROsomes nanoemugel is a promising candidate for targeted topical therapy in skin cancer treatment.
Downloads
References
1. Rieger MM. Barrier function of the skin. J Soc Cosmet Chem. 2001;42:129-34.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7-30. doi: 10.3322/caac.21590, PMID 31912902
3. Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res. 1993;3(6):395-401. doi: 10.1097/00008390- 199311000-00002, PMID 8161879
4. Urbach F. Incidence of nonmelanoma skin cancer. Dermatol Clin. 1991;9(4):751-5.
5. Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. Adv Exp Med Biol. 2008;624:89-103. doi: 10.1007/978-0-387-77574-6_8, PMID 18348450
6. Benson HA. Transdermal drug delivery: Penetration enhancement techniques. Curr Drug Deliv. 2005;2(1):23-33. doi: 10.2174/1567201052772915, PMID 16305405
7. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261-8. doi: 10.1038/nbt.1504, PMID 18997767
8. Müller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev. 2007;59(6):522-30. doi: 10.1016/j.addr.2007.04.012
9. Shakeel F, Shafiq S, Haq N, Alanazi FK, Alsarra IA. Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds. Drug Dev Ind Pharm. 2010;36(11):1251-62.
10. Preeti, Sambhakar S, Malik R, Bhatia S, Al Harrasi A, Rani C, et al. Nanoemulsion: An emerging novel technology for improving the bioavailability of drugs. Scientifica (Cairo). 2023;2023:6640103. doi: 10.1155/2023/6640103
11. Hashem FM, Shaker DS, Ghorab MK, Nasr M, Ismail A. Formulation, characterization, and clinical evaluation of microemulsion containing clotrimazole for topical delivery. AAPS PharmSciTech. 2011 Sep;12(3):879-86. doi: 10.1208/s12249-011-9653-7
12. Nadkarni KM. Indian Materia Medica. Mumbai: Bombay Popular Prakashan; 2009.
13. Patel SS, Jesuraj SA, Kumar ES, Saminathan K, Suthakaran R, Kumar MR, et al. Wound healing activity of Mimosa pudica Linn formulation. Asian Pac J Trop Biomed. 2012;2(6):543-7.
14. Vallinayaki KN, Shanmugam R. Evaluation of antidiabetic activity and cytotoxic effect of strontium nanoparticles synthesized using Mimosa pudica. J Pharm Bioallied Sci. 2024;16 Suppl 2:S1340-S4. doi: 10.4103/jpbs jpbs_583_23
15. Batra P, Sharma AK. Anti-cancer potential of flavonoids: Recent trends and future perspectives. 3 Biotech. 2013;3(6):439-59. doi: 10.1007/ s13205-013-0117-5
16. Rice-Evans C, Miller N, Paganga G. The antioxidant properties of flavonoids and phenolic acids. Trends Plant Sci. 1997;2(4):152-9. doi: 10.1016/S1360-1385(97)01018-2
17. Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009;2(5):270-8. doi: 10.4161/oxim.2.5.9498
18. Jin C, Wang K, Oppong-Gyebi A, Hu J. Application of nanotechnology in cancer diagnosis and therapy - a mini-review. Int J Med Sci. 2020;17(18):2964-73. doi: 10.7150/ijms.49801
19. Tayeb HH, Felimban R, Almaghrabi S, Hasaballah N. Nanoemulsions: Formulation, characterization, biological fate, and potential role against COVID-19 and other viral outbreaks. Colloid Interface Sci Commun. 2021;45:100533. doi: 10.1016/j.colcom.2021
20. Jin C, Wang K, Oppong-Gyebi A, Hu J. Application of nanotechnology in cancer diagnosis and therapy - a mini-review. Int J Med Sci. 2020;17(18):2964-73. doi: 10.7150/ijms.49801
21. Kangara D, Maanisha NW, De Silva HH, Wickramaratne M. Formulation and Development of Mimosa Pudica and Glycyrrhiza Glabra Containing Topical Cream for Hyperpigmentation. In: Bachelor’s Thesis, Industrial Pharmaceutical Science; 2024 Jul. doi: 10.13140/RG.2.2.11046.54087
22. Kumar VR, Kumar S. Formulation and evaluation of Mimosa pudica gel. Int J Pharm Pharm Sci. 2011;3(1):55-7.
23. Patil PS, Salunkhe VR, Bhinge SD, Patil SB, Kumbhar BV. Formulation optimization and evaluation of glycyrrhetinic acid loaded PLARosome using factorial design: In-vitro anti-ulcer activity and in silico PASS prediction. J Indian Chem Soc. 2021;98(11):100199. doi: 10.1016/j. jics.2021.100199
24. Moghimipour E, Salami A, Monjezi M. Formulation and evaluation of liposomes for transdermal delivery of celecoxib. Jundishapur J Nat Pharm Prod. 2015;10(1):e17653. doi: 10.17795/jjnpp-17653, PMID 27747190
25. Gaikwad VK, Laware RB, Mohire NC, Bhinge SD. PLAROsomes as a modified liposomes delivery system for Mimosa pudica L. extract: Augmenting anticancer potential against prostate and skin cancer cell lines. Ann Pharm Fr. 2025:S0003-4509(25)00074-4. doi: 10.1016/j. pharma.2025.04.004.
26. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. Liposome: Classification, preparation, and applications. Nanoscale Res Lett. 2013;8(1):102. doi: 10.1186/1556-276X-8-102, PMID 23432972
27. Jadhav ST, Salunkhe VR, Bhinge SD. Nanoemulsion drug delivery system loaded with imiquimod: A QbD-based strategy for augmenting anti-cancer effects. Future J Pharm Sci. 2023;9(1):120. doi: 10.1186/ s43094-023-00568-z
28. Jadhav ST, Salunkhe VR, Bhinge SD, Honmane SM, Jadhav AS. Development and evaluation of imiquimod-loaded nanoemulsion-based gel for the treatment of skin cancer. Future J Pharm Sci. 2024;10(1):93. doi: 10.1186/s43094-024-00660-y
29. Kumar L, Verma R. In vitro evaluation of topical gel prepared using natural polymer. Int J Drug Delivery. 2010;2(1):58-63. doi: 10.5138/ ijdd.2010.0975.0215.02012
30. Gaber DA, Alsubaiyel AM, Alabdulrahim AK, Alharbi HZ, Aldubaikhy RM, Alharbi RS, et al. Nano-emulsion based gel for topical delivery of an anti-inflammatory drug: In vitro and in vivo evaluation. Drug Des Dev Ther. 2023;17:1435-51. doi: 10.2147/DDDT.S407475, PMID 37216175
31. Shi Y, Zhang M, Chen K, Wang M. Nano-emulsion prepared by high pressure homogenization method as a good carrier for Sichuan pepper essential oil: Preparation, stability, and bioactivity. LWT. 2022;154:112779. doi: 10.1016/j.lwt.2021.112779
32. Bhinge SD, Kamalakar SP, Randive DS, Bhutkar MA, Patil KS, Merekar AN, et al. Development and characterization of stable proanthocyanidin-loaded PLAROsomes as a potential drug carrier system for augmenting anticancer activity. Eur J Lipid Sci Technol. 2024;126(6):2300218. doi: 10.1002/ejlt.202300218
33. Lu WC, Huang DW, Wang CR, Yeh CH, Tsai JC, Huang YT, et al. Preparation, characterization, and antimicrobial activity of nanoemulsions incorporating citral essential oil. J Food Drug Anal. 2018;26(1):82-9. doi: 10.1016/j.jfda.2016.12.018, PMID 29389592
34. Gibis M, Ruedt C, Weiss J. In vitro release of grape-seed polyphenols encapsulated from uncoated and chitosan-coated liposomes. Food Res Int. 2016;88(A):105-13. doi: 10.1016/j.foodres.2016.02.010, PMID 28847389
35. Patil SS, Chougale RD, Manjappa AS, Disouza JI, Hajare AA, Patil KS. Statistically developed docetaxel-laden mixed micelles for improved therapy of breast cancer. OpenNano. 2023;9:100079. doi: 10.1016/J. ONANO.2022.100079
36. Wallace SJ, Li J, Nation RL, Boyd BJ. Drug release from nanomedicines: Selection of appropriate encapsulation and release methodology. Drug Deliv Transl Res. 2012;2(4):284-92. doi: 10.1007/s13346-012-0064-4, PMID 23110256
37. Bagal AV, Vijay N, Disouza J, Mali GU, Bhinge SD. Anticancer potential of Hemidesmus indicus-enriched Pt/Au bimetallic nanoparticles againsthuman breast and skin cancer cell lines. Nanosci Nanotechnol Asia. 2023;13(6):e281123223950. doi: 10.2174/01221068122665422311170 73659
38. Bhutkar MA, Randive DS, Bhinge SD, Wadkar GH, Todkar SS, Shejawal KP. Development of gold, silver and iron nanoparticles of isolated berberine: its characterization, antimicrobial, and cytotoxic activities against COLO320DM and HeLa cells. Gold Bull. 2022;55(1):93-103. doi: 10.1007/s13404-022-00309-9
39. Shejawal KP, Randive DS, Bhinge SD, Bhutkar MA, Wadkar GH, Todkar SS, et al. Functionalized single-walled carbon nanotube for colon targeted delivery of isolated lycopene from Lycopersicon esculentum in colorectal cancer: Its in-vitro cytotoxicity and in-vivo roentgenographic study. J Mater Res. 2021;36(24):4894-907. doi: 10.1557/s43578-021-00431-y
40. Bhat SS, Revankar VK, Kumbar V, Bhat K, Kawade VA. Synthesis, crystal structure and biological properties of a cis-dichloridebis (diimine)copper(II) complex. Acta Crystallogr Sect C Struct Chem. 2018;C74:146-51.
41. Bhinge SD, Jadhav S, Lade P, Bhutkar MA, Gurav S, Jadhav N, et al. Biogenic nanotransferosomal vesicular system of Clerodendrum serratum L. for skin cancer therapy: Formulation, characterization, and efficacy evaluation. Future J Pharm Sci. 2025;11(1):5. doi: 10.1186/ s43094-024-00755-6.
42. Bhinge SD, Kamalakar SP, Randive DS, Bhutkar MA, Patil KS, Merekar AN, et al. Development and characterization of stable proanthocyanidin-loaded PLAROsomes as a potential drug carrier system for augmenting anticancer activity. Eur J Lipid Sci Technol. 2024;126(6):2300218. doi: 10.1002/ejlt.202300218
43. Bhinge SD, Kamalakar SP, Randive DS, Bhutkar MA, Patil KS, Merekar AN, et al. Development and characterization of stable proanthocyanidin-loaded PLAROsomes as a potential drug carrier system for augmenting anticancer activity. Eur J Lipid Sci Technol. 2024;126(6):2300218. doi: 10.1002/ejlt.202300218
44. Bhinge SD, Kamble S, Randive D, Bhutkar M, Nadaf S, Merekar A, et al. Development, characterization, and assessment of PLAROsomal vesicular system of curcumin for enhanced stability and therapeutic efficacy. Future J Pharm Sci. 2024;10(1):161. doi: 10.1186/s43094- 024-00733-y
45. Gauru I, Alam YS, Santoso M, Fadlan A, Affifah NR, Andifa N, et al. In silico studies and cytotoxicity assay of benzylidene benzo hydrazide derivatives on cancer stem cell. Int J Appl Pharm. 2025;17:134-41. doi: 10.22159/ijap.2025v17i2.53105
46. Jose M, Jaison AC, Mathew A, Suku A, Venugopal S, Jayalakshmi PM. In-vitro cytotoxic study on root extracts of Apama siliquosa Lamk. Int J Pharm Sci Res. 2021;23:3805-13.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Vaishali Gaikwad, RAVINDRA LAWARE, NITIN MOHIRE, SOMNATH BHINGE
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
